Skip to main content
. 2016 May 26;20:157. doi: 10.1186/s13054-016-1344-z

Fig. 3.

Fig. 3

Distribution of classification scores of the AKI marker pattern (upper panel) and NGAL levels in ng/mL (lower panel) in AKI and non-AKI patient subgroups showing either progression or lack of nonocclusive mesenteric ischemia (NOMI) or death. A post hoc test was performed for average rank differences between the different subgroups (each with p < 0.05) after a significant result in the global Kruskal-Wallis test (p < 0.0001). AKI acute kidney injury, NGAL neutrophil gelatinase-associated lipocalin